KURA
Kura Oncology Inc.
$8.32
+$0.22(+2.78%)
20
Overall
--
Value
20
Tech
--
Quality
Market Cap
$724.76M
Volume
1.04M
52W Range
$5.41 - $21.11
Target Price
$25.42
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | -- | -- | -- | -- | -- | -- | -- | -- | -- | $53.9M | ||
| Total Revenue | -- | -- | -- | -- | -- | -- | -- | -- | -- | $53.9M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | -- | -- | -- | -- | -- | -- | -- | -- | -- | $53.9M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-23.9M | $-28.4M | $-36.1M | $-62.9M | $67.5M | $91.9M | $131.3M | $139.9M | $165.8M | $247.1M | ||
| Research & Development | -- | -- | -- | $46.8M | $47.8M | $60.4M | $84.7M | $92.8M | $115.2M | $170.0M | ||
| Research Expense | -- | -- | -- | $46.8M | $47.8M | $60.4M | $84.7M | $92.8M | $115.2M | $170.0M | ||
| Selling, General & Administrative | $69.0K | -- | -- | $16.1M | $19.7M | $31.5M | $46.5M | $47.1M | $50.6M | $77.1M | ||
| Selling & Marketing Expenses | $69.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| General & Administrative Expenses | $-267.0K | $-300.0K | $-400.0K | $16.1M | $19.7M | $31.5M | $46.5M | $47.1M | $50.6M | $77.1M | ||
| Salaries & Wages | $-2.3M | $-2.1M | $-4.5M | $-8.7M | $9.4M | $12.8M | $23.6M | $26.3M | $28.1M | $33.9M | ||
| Depreciation & Amortization | $-20.0K | $-31.0K | $-30.0K | $-10.0K | -- | $200.0K | $600.0K | $800.0K | $800.0K | $800.0K | ||
| Depreciation & Amortization | $-20.0K | $-31.0K | $-30.0K | $-10.0K | -- | $200.0K | $600.0K | $800.0K | $800.0K | $800.0K | ||
| Other Operating Expenses | $23.9M | $28.4M | $36.1M | $-62.9M | $-678.0K | $-1.2M | $-1.4M | $-2.0M | $-3.5M | $-5.3M | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-23.9M | $-28.4M | $-36.1M | $-62.9M | $-67.5M | $-91.9M | $-131.3M | $-139.9M | $-165.8M | $-193.2M | ||
| EBITDA | $-22.4M | $-26.8M | $-34.7M | $-61.2M | $-63.7M | $-88.9M | $-129.5M | $-134.9M | $-162.4M | $-170.6M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $46.0K | $577.0K | $888.0K | $970.0K | $580.0K | $578.0K | $414.0K | $229.0K | $1.5M | -- | ||
| Intinc | $1.3M | $1.4M | $1.5M | $3.9M | $4.7M | $2.9M | $1.2M | $4.3M | $14.7M | $22.8M | ||
| Net Non-Operating Interest Income/Expense | $1.2M | $807.0K | $643.0K | $2.9M | $4.1M | $2.3M | $792.0K | $4.0M | $14.7M | $22.8M | ||
| Gain on Sale of Securities | -- | $69.0K | $30.8M | $93.5M | -- | -- | -- | -- | -- | -- | ||
| Other Income/Expense | -- | $-69.0K | $-30.8M | $498.0K | $-245.0K | $-51.0K | $212.0K | -- | -- | -- | ||
| Other Special Charges | -- | -- | -- | $-498.0K | $245.0K | $51.0K | $-212.0K | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-22.6M | $-27.0M | $-34.5M | $-59.5M | $-62.6M | $-89.0M | $-130.1M | $-135.6M | $-163.7M | $-172.0M | ||
| Pre-Tax Income | $-22.6M | $-27.6M | $-35.4M | $-60.4M | $-63.1M | $-89.6M | $-130.5M | $-135.8M | $-152.6M | $-172.0M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $-29.0K | $-50.0K | $-9.5M | -- | $-4.8M | $-7.7M | $-9.8M | $-9.7M | $-11.0M | $2.0M | ||
| NET INCOME | ||||||||||||
| Net Income | $-22.6M | $-27.6M | $-35.4M | $-60.4M | $-63.1M | $-89.6M | $-130.5M | $-135.8M | $-152.6M | $-174.0M | ||
| Net Income (Continuing Operations) | $-22.6M | $-27.6M | $-35.4M | $-60.4M | $-63.1M | $-89.6M | $-130.5M | $-135.8M | $-152.6M | $-174.0M | ||
| Net Income (Discontinued Operations) | $-22.6M | $-27.6M | $-35.4M | $-60.4M | $-63.1M | $-89.6M | $-130.5M | $-135.8M | $-152.6M | $-174.0M | ||
| Net Income (Common Stockholders) | $-22.6M | $-27.6M | $-35.4M | $-60.4M | $-63.1M | $-89.6M | $-130.5M | $-135.8M | $-152.6M | $-174.0M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-170.2M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-23.9M | $-28.4M | $-36.1M | $-62.9M | $67.5M | $91.9M | $131.3M | $139.9M | $165.8M | $247.1M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $9.9M | $18.7M | $23.2M | $35.2M | $41.9M | $53.1M | $66.4M | $67.0M | $73.2M | $86.2M | ||
| Average Shares Outstanding (Diluted) | $9.9M | $18.7M | $23.3M | $35.1M | $41.9M | $53.1M | $66.4M | $67.0M | $73.2M | $86.2M | ||
| Shares Outstanding | $21.4M | $21.4M | $33.4M | $38.2M | $45.4M | $66.2M | $66.6M | $68.4M | $76.1M | $80.8M | ||
| Basic EPS | -- | -- | -- | -- | $-1.51 | $-1.69 | $-1.97 | $-2.03 | $-2.08 | $-2.02 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | $-1.51 | $-1.69 | $-1.97 | $-2.03 | $-2.08 | $-2.02 | ||
| Diluted EPS | $-2.28 | $-1.47 | $-1.52 | $-1.72 | $-1.51 | $-1.69 | $-1.97 | $-2.03 | $-2.08 | $-2.02 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | -- | -- | $-2.03 | $-2.08 | $-2.02 | ||
| OTHER METRICS | ||||||||||||
| Other Gand A | $-267.0K | $-300.0K | $-400.0K | $16.1M | $19.7M | $31.5M | $46.5M | $47.1M | $50.6M | $77.1M | ||
| Rent And Landing Fees | $-267.0K | $-300.0K | $-400.0K | $16.1M | $600.0K | $2.0M | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KURA | $8.32 | +2.8% | 1.04M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |